Ontosight.ai vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-09-01
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionOntosight.aiIsomorphic Labs
PricingFreemium (Pro/Team plans available)Contact-based (enterprise partnerships only)
Target UsersIndividual researchers, students, medical writersLarge pharma companies, research institutions
Core CapabilitiesConversational Q&A, summarization, manuscript drafting citing PubMed, DrugBank, etc.Predictive/generative AI for protein-ligand interactions, novel molecule design
Integration & DeliveryWeb platform with PubMed, DrugBank, ClinicalTrials.gov integrationsPharma partnership model, no standalone API or product
Latest NewsNo recent newsSeries B (Feb 2026), J&J collaboration, $600M funding (2025), US ops (2025)
Best ForBiomedical literature research, clinical guideline lookupsLarge-scale drug discovery lead optimization

If you're an individual researcher needing a life sciences research assistant with citations, Ontosight.ai's freemium model and integrations are immediately usable. If you're a large pharma company seeking to accelerate drug discovery at scale, Isomorphic Labs' AI-first platform, backed by AlphaFold and major partnerships, is the clear choice—but it requires a deep collaboration commitment.

Ontosight.ai
Ontosight.ai

Conversational AI for life sciences research, literature synthesis, and clinical insights.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-native drug discovery partner building on AlphaFold for pharma R&D.

Visit Website
Pricing
Freemium
Contact Sales
Plans
$0/month
$29/month
$99/month
Popularity
3 views
7.4k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
Categories
🔬 Research & Education Document Q&A & Summarizing🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Conversational Q&A with source citations
Smart literature synthesis and gap analysis
Chat with uploaded PDFs
AI summarization of papers and abstracts
Drug mechanism and interaction queries
Clinical guideline lookups
Export answers as PDF or CSV
Bookmark and conversation history
Multi-turn context-aware follow-ups
Team collaboration workspaces (Pro/Team)
Natural language to database queries
Customizable response verbosity
PubMed integration
DrugBank integration
ClinicalTrials.gov integration
Drug Design Engine for generative molecule design
Predictive and generative AI models for drug discovery
AlphaFold-based structure prediction
Simulation of drug behavior and performance
End-to-end research collaborations from target to lead
Digital biology simulation at scale
Bioresilience framework for pandemic preparedness
Collaborative R&D with major pharma partners
Target identification and lead optimization support
US operations since 2025
Integrations
PubMed
DrugBank
ClinicalTrials.gov
UniProt
GeneCards
NCBI
PharmGKB

What real users say: Ontosight.ai vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Ontosight.ai

21 mentions across 3 sources · 30% positive — critical

Hacker News, YouTube, Product Hunt

What users praise

  • Finds relevant, cited literature for biomedical queries.
  • Tailored to life sciences, giving it an edge over general-purpose AI.
  • Integration with PubMed, DrugBank, and ClinicalTrials.gov is valuable.
  • Multi-turn conversations let you dig deeper into a topic.

What frustrates them

  • Source listings lack inline pointers—users can't verify claims easily.
  • Only available via web; no mobile or desktop app for on-the-go.
  • Team features locked behind Pro/Team, pushing costs up fast.
  • No independent comparison against Perplexity or Elicit yet.

Researched Sep 1, 2026

Isomorphic Labs

46 mentions across 3 sources · 73% positive

Hacker News, YouTube, Lemmy

What users praise

  • Backed by DeepMind's AlphaFold legacy and Nobel-winning science.
  • Massive pharma partnerships: Novartis, J&J, Eli Lilly.
  • Drug Design Engine (July 2026) moves beyond structure prediction.
  • Generative AI for molecule design, simulating drug behavior.

What frustrates them

  • Not a self-serve tool; partnership-only model limits access.
  • CASP16 shows no clear advantage over older prediction methods.
  • Clinical outcomes unproven; no approved drugs yet.
  • Returns tied to performance milestones, uncertain timeline.

Researched Aug 26, 2026

Who should pick which

  • Biomedical PhD student
    Pick: Ontosight.ai

    Needs quick summarization and citation from PubMed; Ontosight.ai's freemium plan and natural language queries fit perfectly.

  • Large pharma R&D director
    Pick: Isomorphic Labs

    Aims to accelerate lead optimization with AI; Isomorphic Labs' partnership model and AlphaFold integration provide cutting-edge predictive power.

  • Medical writer reporting on clinical trials
    Pick: Ontosight.ai

    Can use Ontosight.ai to draft manuscripts with cited sources from ClinicalTrials.gov and PubMed.

  • Small biotech exploring drug repurposing
    Pick: Ontosight.ai

    Ontosight.ai can quickly retrieve drug interaction data; Isomorphic Labs' partnership model is too heavy for early-stage exploration.

  • Academic research group studying protein structures
    Pick: Isomorphic Labs

    If partnered with a pharma company, they could access Isomorphic Labs' AlphaFold-based predictions; otherwise, non-partnered academics should use public AlphaFold.

Frequently Asked Questions

Ontosight.ai vs Isomorphic Labs: which should you choose?

If you're an individual researcher needing a life sciences research assistant with citations, Ontosight.ai's freemium model and integrations are immediately usable. If you're a large pharma company seeking to accelerate drug discovery at scale, Isomorphic Labs' AI-first platform, backed by AlphaFold and major partnerships, is the clear choice—but it requires a deep collaboration commitment.

Can I use Ontosight.ai for drug discovery?

It aids literature review and data retrieval, but not predictive molecule design—that's Isomorphic Labs' domain.

Is Isomorphic Labs available as a SaaS product?

No. It operates through pharma collaborations only—no standalone API or web interface.

Which tool is better for a student?

Ontosight.ai with its freemium model and PubMed integration is ideal.

Does Isomorphic Labs have recent funding?

Yes, a $600M external round in 2025 and a Series B in February 2026.

Can Ontosight.ai handle chemical structure queries?

It references databases like DrugBank but does not generate novel molecules.

What partnerships does Isomorphic Labs have?

It collaborates with Novartis and Johnson & Johnson (announced Jan 2026).

Does Ontosight.ai support team collaboration?

Yes, through its Pro/Team plans with shared workspaces.

Which tool is more cost-effective for a startup?

Ontosight.ai's freemium model is affordable; Isomorphic Labs requires large-scale investment.

More Ontosight.ai or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026